Argent Capital Management LLC Incyte Corp Transaction History

Argent Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$76.02 - $100.5 $18 Million - $23.8 Million	-236,879 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$80.74 - $97.7 $1.41 Million - $1.71 Million	-17,520 Reduced 6.89%	236,879 $20.6 Million
Q3 2020 Nov 10, 2020	SELL	$85.07 - $109.69 $410,207 - $528,925	-4,822 Reduced 1.86%	254,399 $22.8 Million
Q2 2020 Aug 10, 2020	SELL	$74.18 - $108.93 $1.65 Million - $2.42 Million	-22,240 Reduced 7.9%	259,221 $27 Million
Q1 2020 May 13, 2020	SELL	$63.18 - $85.97 $561,480 - $764,015	-8,887 Reduced 3.06%	281,461 $20.6 Million
Q4 2019 Feb 10, 2020	SELL	$73.04 - $95.72 $325,247 - $426,241	-4,453 Reduced 1.51%	290,348 $25.4 Million
Q3 2019 Nov 07, 2019	BUY	$72.82 - $86.52 $118,842 - $141,200	1,632 Added 0.56%	294,801 $21.9 Million
Q2 2019 Aug 15, 2019	SELL	$73.52 - $88.7 $1.82 Million - $2.2 Million	-24,769 Reduced 7.79%	293,169 $24.9 Million
Q1 2019 May 10, 2019	BUY	$63.56 - $88.17 $20.2 Million - $28 Million	317,938 New	317,938 $27.3 Million

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Argent Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Argent Capital Management LLC with notifications on news.